Document is current
Any future updates will be listed below
-
Authors
Tiwari, Mansi http://orcid.org/0009-0003-7665-0878
Roumane, Ahlima http://orcid.org/0000-0001-6831-4426
Sommer, Nadine http://orcid.org/0000-0003-2380-7117
Han, Weiping
Delibegović, Mirela
Rochford, Justin J.
Mcilroy, George D. http://orcid.org/0000-0003-4230-4355
-
Funding
Funding for this research was provided by:
Diabetes UK (21/0006280)
University of Aberdeen (DTG)
RCUK | Biotechnology and Biological Sciences Research Council (EASTBIO PhD Studentship, BB/V015869/1)
- License Information
-
More Information
Article History
Received: 3 May 2024
Revised: 17 July 2024
Accepted: 22 July 2024
First Online: 28 July 2024
Competing interests
: GDM and JJR are co-inventors on a patent application for the use of gene therapies designed for the treatment of conditions of lipodystrophy.
: Procedures on wild type (WT) and seipin knockout (SKO) mice were approved by the University of Aberdeen Ethics Review Board and performed under the Animals (Scientific Procedures) Act 1986 under project license (PPL: P1ECEB2B6) approved by the UK Home Office.
